Question 1

Am I eligible to participate in this trial based on my kidney function?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet clinical trial (NCT02108639). Contact the study team or your healthcare provider for specific answers.

Question 2

How might this trial help me with my Hepatitis C treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet clinical trial (NCT02108639). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the drugs being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet clinical trial (NCT02108639). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet clinical trial (NCT02108639). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will be done during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet clinical trial (NCT02108639). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any other treatment options I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet clinical trial (NCT02108639). Contact the study team or your healthcare provider for specific answers.

What this study is about